| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
IRON
Disc Medicine
|
Jun 16, 2026 | BUY |
Strong Buy
+20.3% avg upside
21 analysts
|
— | · |
|
DNTH
Dianthus Therapeutics
|
Jun 15, 2026 | BUY |
Strong Buy
+8.9% avg upside
29 analysts
|
— | -4.4% |
|
ARGX
Argenx Se
|
Jun 09, 2026 | BUY |
Strong Buy
-15.8% avg upside
46 analysts
|
— | -0.2% |
|
CLYM
Climb Bio
|
Jun 02, 2026 | BUY |
Strong Buy
+57.9% avg upside
18 analysts
|
— | · |
|
PRAX
Praxis Precision Medicines
|
Jun 02, 2026 | BUY |
Strong Buy
+92.1% avg upside
24 analysts
|
$616.00
118.14% Upside
|
+4.6% |
|
APGE
Apogee Therapeutics
|
May 28, 2026 | HOLD |
Strong Buy
+28.7% avg upside
19 analysts
|
$81.00
10.46% Downside
|
+13.6% |
|
VRTX
Vertex Pharmaceuticals
|
May 27, 2026 | BUY |
Strong Buy
-2.7% avg upside
61 analysts
|
$542.00
20.04% Upside
|
+5.0% |
|
IMVT
Immunovant
|
May 22, 2026 | HOLD |
Strong Buy
+9.0% avg upside
24 analysts
|
$30.00
15.05% Downside
|
+1.6% |
|
PVLA
Palvella Therapeutics
|
May 21, 2026 | BUY |
Strong Buy
+45.4% avg upside
27 analysts
|
— | -2.4% |
|
RAPP
Rapport Therapeutics, Inc.
|
May 19, 2026 | BUY |
Strong Buy
+46.2% avg upside
12 analysts
|
$56.00
49.96% Upside
|
+7.3% |
|
WVE
Wave Life Sciences
|
May 19, 2026 | BUY |
Strong Buy
+261.8% avg upside
28 analysts
|
— | +0.3% |
|
INSM
Insmed
|
May 18, 2026 | BUY |
Strong Buy
+82.1% avg upside
36 analysts
|
$185.00
93.10% Upside
|
-8.1% |
|
BIIB
Biogen
|
May 15, 2026 | HOLD |
Strong Buy
+25.1% avg upside
51 analysts
|
— | +3.0% |
|
MAZE
Maze Therapeutics, Inc.
|
May 14, 2026 | BUY |
Strong Buy
+145.3% avg upside
12 analysts
|
— | -6.0% |
|
UPB
Upstream Bio, Inc.
|
May 14, 2026 | BUY |
Strong Buy
+514.9% avg upside
9 analysts
|
$43.00
588.00% Upside
|
-26.6% |
|
TECX
Tectonic Therapeutic
|
May 11, 2026 | BUY |
Strong Buy
+88.0% avg upside
24 analysts
|
$60.00
99.96% Upside
|
+1.3% |
|
BBIO
BridgeBio Pharma
|
May 11, 2026 | BUY |
Strong Buy
+38.3% avg upside
34 analysts
|
$102.00
53.96% Upside
|
+4.2% |
|
HRMY
Harmony Biosciences Holdings
|
May 08, 2026 | HOLD |
Strong Buy
+39.5% avg upside
13 analysts
|
$29.00
12.87% Downside
|
-2.9% |
|
NBIX
Neurocrine
|
May 07, 2026 | BUY |
Strong Buy
+7.8% avg upside
37 analysts
|
$155.00
2.05% Downside
|
+6.8% |
|
ALNY
Alnylam Pharma
|
May 01, 2026 | BUY |
Strong Buy
+23.4% avg upside
51 analysts
|
— | -4.5% |
|
CNTA
Centessa Pharmaceuticals
|
Apr 12, 2026 | HOLD |
Buy
-14.4% avg upside
19 analysts
|
$38.00
5.05% Downside
|
+0.7% |
|
QURE
uniQure
|
Dec 10, 2024 | BUY |
Strong Buy
+16.1% avg upside
29 analysts
|
$8.98
80.68% Downside
|
+31.6% |
|
RGNX
RegenXBio
|
Nov 18, 2024 | BUY |
Strong Buy
+381.2% avg upside
22 analysts
|
$18.00
130.82% Upside
|
+10.8% |
|
PTCT
PTC Therapeutics
|
Oct 10, 2024 | HOLD |
Buy
-1.4% avg upside
29 analysts
|
— | +72.1% |
|
SRPT
Sarepta Therapeutics
|
Oct 10, 2024 | BUY |
Buy
+246.5% avg upside
49 analysts
|
$150.00
755.72% Upside
|
-81.9% |
|
ACAD
ACADIA Pharmaceuticals
|
Oct 10, 2024 | HOLD |
Strong Buy
+66.0% avg upside
42 analysts
|
— | +37.9% |
|
BMRN
BioMarin Pharmaceutical
|
Oct 10, 2024 | BUY |
Strong Buy
+72.7% avg upside
52 analysts
|
$79.00
44.40% Upside
|
-25.1% |
|
DNLI
Denali Therapeutics
|
Oct 10, 2024 | HOLD |
Strong Buy
+60.2% avg upside
24 analysts
|
— | -40.3% |
|
XENE
Xenon
|
Oct 10, 2024 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$50.00
5.58% Downside
|
-1.9% |
|
AGIO
Agios Pharma
|
Oct 10, 2024 | BUY |
Strong Buy
+73.8% avg upside
29 analysts
|
$51.00
49.22% Upside
|
-2.9% |
|
KYNB
Kyntra Bio
|
Jun 26, 2023 | HOLD |
Buy
+369.6% avg upside
14 analysts
|
— | -61.1% |
|
PASG
Passage Bio
|
May 16, 2022 | BUY |
Buy
+214.0% avg upside
14 analysts
|
$10.00
78.81% Upside
|
-40.8% |
|
VERX
Vertex
|
Jun 30, 2021 | HOLD |
Buy
+224.5% avg upside
22 analysts
|
— | -48.4% |
|
KROS
Keros Therapeutics
|
May 27, 2020 | BUY |
Strong Buy
+139.8% avg upside
21 analysts
|
$45.00
322.50% Upside
|
+86.0% |
|
ALKS
Alkermes
|
Feb 13, 2020 | HOLD |
Strong Buy
-17.5% avg upside
34 analysts
|
— | +14.6% |
|
AXSM
Axsome Therapeutics
|
Dec 16, 2019 | BUY |
Strong Buy
-10.5% avg upside
28 analysts
|
$125.00
50.05% Downside
|
+0.8% |
|
CBIO
Crescent Biopharma
|
Nov 07, 2019 | HOLD |
Strong Buy
+26.4% avg upside
17 analysts
|
$5.00
71.67% Downside
|
· |
|
GILD
Gilead Sciences
|
Jul 26, 2016 | HOLD |
Strong Buy
-4.8% avg upside
66 analysts
|
— | -5.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.